Success for gene therapy: render unto Caesar that which is Caesar's

par Qiao, Jian, Diaz, Rosa Maria, Vile, Richard G
Publié 2004

Oncolytic Viruses: Priming Time for Cancer Immunotherapy

par Russell, Luke, Peng, Kah Whye, Russell, Stephen J., Diaz, Rosa Maria
Publié dans BioDrugs (2019)

Adoptive Transfer of Cytotoxic T Lymphocytes Targeting Two Different Antigens Limits Antigen Loss and Tumor Escape

par Kaluza, Karen M., Kottke, Timothy, Diaz, Rosa Maria, Rommelfanger, Diana, Thompson, Jill, Vile, Richard
Publié 2012

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs e...

par Merrick, Alison, Diaz, Rosa Maria, O’Donnell, Dearbhaile, Selby, Peter, Vile, Richard, Melcher, Alan
Publié 2007

Single-Cycle Viral Gene Expression, Rather Than Progressive Replication and Oncolysis, Is Required for VSV Therapy of B16 Melanoma

par Galivo, Feorillo, Diaz, Rosa Maria, Wongthida, Phonphimon, Thompson, Jill, Kottke, Timothy, Barber, Glen, Melcher, Alan, Vile, Richard
Publié 2009

Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus

par Wongthida, Phonphimon, Diaz, Rosa Maria, Pulido, Christine, Rommelfanger, Diana, Galivo, Feorillo, Kaluza, Karen, Kottke, Timothy, Thompson, Jill, Melcher, Alan, Vile, Richard
Publié 2011

Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer

par Wongthida, Phonphimon, Diaz, Rosa Maria, Galivo, Feorillo, Kottke, Timothy, Thompson, Jill, Pulido, Jose, Pavelko, Kevin, Pease, Larry, Melcher, Alan, Vile, Richard
Publié 2010

Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the Literature

par Cabezon-Gutierrez, Luis, Franco-Moreno, Ana Isabel, Khosravi-Shahi, Parham, Custodio-Cabello, Sara, Garcia-Navarro, Maria Jose, Martin-Diaz, Rosa Maria
Publié dans World J Oncol (2015)

Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2

par Kottke, Timothy, Thompson, Jill, Diaz, Rosa Maria, Pulido, Jose, Willmon, Candice, Coffey, Matt, Selby, Peter, Melcher, Alan, Harrington, Kevin, Vile, Richard G.
Publié 2009

Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus

par Galivo, Feorillo, Diaz, Rosa Maria, Thanarajasingam, Uma, Jevremovic, Dragan, Wongthida, Phonphimon, Thompson, Jill, Kottke, Timothy, Barber, Glen N., Melcher, Alan, Vile, Richard G.
Publié 2010

Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice

par Kottke, Timothy, Hall, Geoff, Pulido, Jose, Diaz, Rosa Maria, Thompson, Jill, Chong, Heung, Selby, Peter, Coffey, Matt, Pandha, Hardev, Chester, John, Melcher, Alan, Harrington, Kevin, Vile, Richard
Publié 2010

Expression of Interferon-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma

par Willmon, Candice L., Saloura, Vassiliki, Fridlender, Zvi G., Wongthida, Phonphimon, Diaz, Rosa Maria, Thompson, Jill, Kottke, Timothy, Federspiel, Mark, Barber, Glen, Albelda, Steven M., Vile, Richard G.
Publié 2009

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

par Rajani, Karishma, Parrish, Christopher, Kottke, Timothy, Thompson, Jill, Zaidi, Shane, Ilett, Liz, Shim, Kevin G, Diaz, Rosa-Maria, Pandha, Hardev, Harrington, Kevin, Coffey, Matt, Melcher, Alan, Vile, Richard
Publié dans Mol Ther (2016)

Treg Depletion–enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus

par Kottke, Timothy, Galivo, Feorillo, Wongthida, Phonphimon, Diaz, Rosa Maria, Thompson, Jill, Jevremovic, Dragan, Barber, Glen N, Hall, Geoff, Chester, John, Selby, Peter, Harrington, Kevin, Melcher, Alan, Vile, Richard G
Publié 2008

Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma

par Pulido, Jose, Kottke, Timothy, Thompson, Jill, Galivo, Feorillo, Wongthida, Phonphimon, Diaz, Rosa Maria, Rommelfanger, Diana, Ilett, Elizabeth, Pease, Larry, Pandha, Hardev, Harrington, Kevin, Selby, Peter, Melcher, Alan, Vile, Richard
Publié 2012

Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus

par Qiao, Jian, Wang, Hongxun, Kottke, Timothy, White, Christine, Twigger, Katie, Diaz, Rosa Maria, Thompson, Jill, Selby, Peter, de Bono, Johann, Melcher, Alan, Pandha, Hardev, Coffey, Matt, Vile, Richard, Harrington, Kevin
Publié 2008

Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse

par Boisgerault, Nicolas, Kottke, Timothy, Pulido, Jose, Thompson, Jill, Diaz, Rosa Maria, Rommelfanger-Konkol, Diana, Embry, Addie, Saenz, Dyana, Poeschla, Eric, Pandha, Hardev, Harrington, Kevin, Melcher, Alan, Selby, Peter, Vile, Richard
Publié 2013

Broad Antigenic Coverage Induced by Viral cDNA Library-based Vaccination Cures Established Tumors

par Kottke, Timothy, Errington, Fiona, Pulido, Jose, Galivo, Feorillo, Thompson, Jill, Wongthida, Phonphimon, Diaz, Rosa Maria, Chong, Heung, ILett, Elizabeth, Chester, John, Pandha, Hardev, Harrington, Kevin, Selby, Peter, Melcher, Alan, Vile, Richard
Publié 2011

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling

par Cockle, Julia V., Rajani, Karishma, Zaidi, Shane, Kottke, Timothy, Thompson, Jill, Diaz, Rosa Maria, Shim, Kevin, Peterson, Tim, Parney, Ian F., Short, Susan, Selby, Peter, Ilett, Elizabeth, Melcher, Alan, Vile, Richard
Publié dans Neuro Oncol (2016)

Relapsing–Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment

par Cunill, Vanesa, Massot, Margarita, Clemente, Antonio, Calles, Carmen, Andreu, Valero, Núñez, Vanessa, López-Gómez, Antonio, Díaz, Rosa María, Jiménez, María de los Reyes, Pons, Jaime, Vives-Bauzà, Cristòfol, Ferrer, Joana Maria
Publié dans Front Immunol (2018)